28 September 2021 | News
The new division will enhance lung disease management
Mumbai-based pharma firm Alkem Laboratories has launched Pulmocare, a division to enhance awareness, diagnosis and management for lung diseases like asthma, COPD, allergy, advanced lung diseases and lung infections through a wide range of products for lung care.
The objective is to bring a drastic change in lung treatment accessibility in India by way of early diagnosis, better patient reach and signified health promotion.
Sandeep Singh, MD, Alkem Laboratories, stated. “Taking the stock of filling the massive gap of accessibility of lung care for the larger populace in India, we have decided to take a big leap to address the huge lung diseases burden in the country by launching a comprehensive lung care division – Pulmocare. With the Alkem launch of the Pulmocare division, we shall spread awareness about the disease amongst the patients and encourage them to use correct medication.”